FormDSignal

Spero Therapeutics, Inc. (SPRO)

1 Item 5.02 filing since 2026-10-27 · roles: COO. Nasdaq. Pharmaceutical Preparations. State: MA.

ScoreFiledEventRolePersonSeatSummary
452026-10-27Retirement announcedCOOsubscribers—Spero Therapeutics, Inc. (SPRO): COO Timothy Keutzer to retire

Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works